Merck & Co.: Clinical Trials & Research Profile
Biopharma Industry (Rahway, NJ) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Rahway, NJ) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 201 active (101 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 439 (270 with California sites) |
| Completed vs Early-Stopped Studies | 195 completed / 43 stopped (9.8% stop rate) |
| Median Closed Enrollment | 302 participants |
| FDA Drugs@FDA Original Approvals | 183 all-time (15 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 99.9% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Merck & Co. across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk